TYROBP and breast cancer: For the DAP12 interaction pathway, Shabo et al. studied the relationship between DAP12 expression in breast cancer cells and disease progression and found that breast cancer patients with high DAP12 expression had poor prognosis, high recurrence rates and short survival times due to liver metastasis [69] (Figure 5).